RAPT Therapeutics (RAPT) Insider Trading & Ownership → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free RAPT Stock Alerts $7.86 -0.09 (-1.13%) (As of 04/22/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability RAPT Therapeutics (NASDAQ:RAPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$181,961.44 Get RAPT Insider Trade Alerts Want to know when executives and insiders are buying or selling RAPT Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RAPT Insider Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry RAPT Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/5/2024Dirk G BrockstedtInsiderSell898$22.78$20,456.44 12/21/2023William HoInsiderSell2,500$21.68$54,200.00 11/28/2023William HoInsiderSell1,500$13.72$20,580.00 10/3/2023William HoInsiderSell2,500$15.77$39,425.00 8/18/2023William HoInsiderSell2,500$18.92$47,300.00 (Data available from 1/1/2013 forward) RAPT Insider Trading Activity - Frequently Asked Questions Who is on RAPT Therapeutics's Insider Roster? The list of insiders at RAPT Therapeutics includes Dirk G Brockstedt, Group Ii Lp Column, Rodney Kb Young, Wendye Robbins, and William Ho. Learn more on insiders at RAPT. What percentage of RAPT Therapeutics stock is owned by insiders? 6.60% of RAPT Therapeutics stock is owned by insiders. Learn more on RAPT's insider holdings. Which RAPT Therapeutics insiders have been buying company stock? The following insiders have purchased RAPT shares in the last 24 months: Group Ii Lp Column ($13,489,105.00), Rodney Kb Young ($52,650.00), and Wendye Robbins ($98,055.00). How much insider buying is happening at RAPT Therapeutics? Insiders have purchased a total of 1,274,136 RAPT shares in the last 24 months for a total of $13,639,810.00 bought. Which RAPT Therapeutics insiders have been selling company stock? The following insiders have sold RAPT shares in the last 24 months: Dirk G Brockstedt ($47,594.18), and William Ho ($1,126,170.00). How much insider selling is happening at RAPT Therapeutics? Insiders have sold a total of 52,860 RAPT Therapeutics shares in the last 24 months for a total of $1,173,764.18 sold. More Insider Trading Tools from MarketBeat Related Companies: AQST Insider Ownership XOMA Insider Ownership VSTM Insider Ownership NKTR Insider Ownership ERAS Insider Ownership XBIT Insider Ownership AKBA Insider Ownership PYXS Insider Ownership PRLD Insider Ownership CRMD Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:RAPT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
